Evidence map›Paper›PMID 39256797›Full record

ArticleBMC rheumatology2024

Acrocyanosis as a rare presentation of drug-induced cutaneous vasculitis: a case report.

Ezwan Rafizi Zakaria, Wan Syamimee Wan Ghazali, Hafsah Sazali, Nor Shuhaila Shahril, Salzihan Md Salleh, Siti Nurbaya Mohd Nawi

Abstract read
In one paragraph

Article in BMC rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ezwan Rafizi ZakariaSchool of Medical Sciences, Universiti Sains Malaysia, Health Campus Kubang Kerian, Kota Bharu, Kelantan, 16150, Malaysia.
Wan Syamimee Wan GhazaliSchool of Medical Sciences, Universiti Sains Malaysia, Health Campus Kubang Kerian, Kota Bharu, Kelantan, 16150, Malaysia.
Hafsah SazaliSchool of Medical Sciences, Universiti Sains Malaysia, Health Campus Kubang Kerian, Kota Bharu, Kelantan, 16150, Malaysia.
Nor Shuhaila ShahrilDepartment of Medicine, Hospital Putrajaya, Wilayah Persekutuan Putrajaya, Putrajaya, Malaysia.
Salzihan Md SallehSchool of Medical Sciences, Universiti Sains Malaysia, Health Campus Kubang Kerian, Kota Bharu, Kelantan, 16150, Malaysia.
Siti Nurbaya Mohd NawiSchool of Medical Sciences, Universiti Sains Malaysia, Health Campus Kubang Kerian, Kota Bharu, Kelantan, 16150, Malaysia. nurbayanawi@usm.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcrocyanosis is characterised by persistent bluish discolouration of the extremities, resulting from reduced peripheral blood flow leading to increased oxygen extraction. The aetiology can be divided into primary and secondary causes. While primary acrocyanosis is generally painless and has a benign course, secondary causes may lead to complications. This case reported acrocyanosis secondary to cutaneous vasculitis which progressed to digital gangrene, which is a rare complication of cutaneous vasculitis. CASE PRESENTATION: A 68-year-old man presented with a four-day history of bluish discolouration involving bilateral toes associated with pain and started to become gangrenous. Investigations for critical limb ischemia did not show evidence of critical arterial stenosis. Further history revealed history of recent administration of intramuscular injections with diclofenac, a non-steroidal anti-inflammatory agent for renal colic pain a few days prior to the onset of the. Thorough skin search showed multiple purpuric rash of his thighs, buttocks and abdomen. Skin biopsy confirmed the diagnosis of cutaneous (lymphocytic) vasculitis, which was likely to be drug-induced. The acrocyanosis initially responded to methylprednisolone, however unfortunately it progressed further to digital gangrene which required bilateral transmetatarsal amputations.

conclusionKnowledge on clinical features, aetiology and investigations of secondary acrocyanosis is crucial for early recognition and treatment of the underlying cause to prevent irreversible complications.

Indexed as

Bluish discolourationGangreneNSAID-inducedPeripheral cyanosisSkin biopsy

Identifiers

PMID39256797
PMCPMC11384702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.